ANTABIO

Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need. It develops stand-alone inhibitors of bacterial metalloenzymes that can be combined with various antibiotics to restore their activity against the most critical pathogens. The company's novel inhibitor of bacterial Metallo ß-lactamases (“MBLs”) which will be combined with a carbapenem to fill an important gap in the tr... eatment of drug-resistant infections. They develop a novel, safe and efficacious inhibitor of bacterial Metallo ß-lactamases to be combined with a carbapenem for the treatment of drug-resistant nosocomial infections. Antabio received a Wellcome Trust Seeding Drug Discovery Award. The company was founded in 2009 and is headquartered in Labege, France.

#People #Financial #Website #More

ANTABIO

Social Links:

Twitter

Industry:

Biotechnology Life Science Medical Device

Founded:

2009-01-01

Address:

Labège, Midi-Pyrenees, France

Country:

France

Website Url:

http://www.antabio.com

Total Employee:

11+

Status:

Active

Contact:

+33 5 61 53 88 43

Email Addresses:

[email protected]

Total Funding:

43.48 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Apache